ACRV: Acrivon Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 261.50
Enterprise Value ($M) 225.49
Book Value ($M) 121.19
Book Value / Share 3.93
Price / Book 2.16
NCAV ($M) 112.62
NCAV / Share 3.65
Price / NCAV 2.32

Profitability (mra)
Return on Invested Capital (ROIC) -0.48
Return on Assets (ROA) -0.35
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 9.75
Current Ratio 9.75

Balance Sheet (mrq) ($M)
Current Assets 129.69
Assets 138.26
Liabilities 17.07
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -67.10
Net Income -60.39

Cash Flow Statement (mra) ($M)
Cash From Operations -42.64
Cash from Investing 50.72
Cash from Financing -1.55

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-15 13G/A Perceptive Advisors Llc 17.40 78.23
04-11 13D/A Ra Capital Management, L.p. 27.10 73.52
02-14 13G/A Citadel Advisors Llc 7.40
02-14 13G/A Marshall Wace North America L.P. 2.70 -51.16
02-13 13G/A Sands Capital Ventures, LLC 7.40 -0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q Form 10-Q
2023-05-09 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 28,383 90,418 31.39
2024-04-25 134,018 154,501 86.74
2024-04-24 23,612 70,911 33.30
2024-04-23 56,721 69,656 81.43
2024-04-22 34,296 56,085 61.15

(click for more detail)

Similar Companies
ACAB – Atlantic Coastal Acquisition Corp. II ACET – Adicet Bio, Inc.
ACIU – AC Immune SA ADMA – ADMA Biologics, Inc.
ALIM – Alimera Sciences, Inc.


Financial data and stock pages provided by
Fintel.io